Hirofumi Izaki
- Pulmonary and Respiratory Medicine
- Surgery
- Molecular Biology
- Pediatrics, Perinatology and Child Health
- Obstetrics and Gynecology top 10%
- Co-authors
- Hiro‐omi KanayamaTomoharu FukumoriMasayuki TakahashiTomoteru KishimotoNatsuo OkaHiroyoshi NakatsujiMasaaki NishitaniKunihisa Yamaguchi
- Topics
- Bladder and Urothelial Cancer Treatments (17 papers)Ureteral procedures and complications (11 papers)Urological Disorders and Treatments (11 papers)
- Journals
- SHILAP Revista de lepidopterologíaEuropean Heart JournalThe Journal of Urology
In The Last Decade
Hirofumi Izaki
48 papers receiving 342 citations
Peers
Comparison fields: 5 of 61
- Pulmonary and Respiratory Medicine 155
- Surgery 152
- Molecular Biology 87
- Pediatrics, Perinatology and Child Health 69
- Obstetrics and Gynecology 64
Countries citing papers authored by Hirofumi Izaki
This map shows the geographic impact of Hirofumi Izaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Izaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Izaki more than expected).
Fields of papers citing papers by Hirofumi Izaki
This network shows the impact of papers produced by Hirofumi Izaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Izaki. The network helps show where Hirofumi Izaki may publish in the future.
Co-authorship network of co-authors of Hirofumi Izaki
This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Izaki. A scholar is included among the top collaborators of Hirofumi Izaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Izaki. Hirofumi Izaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 2 | |
| 9 | 3 | |
| 10 | 10 | |
| 11 | 4 | |
| 12 | 1 | |
| 13 | 25 | |
| 14 | 2 | |
| 15 | 3 | |
| 16 | 5 | |
| 17 | 41 | |
| 18 | 24 | |
| 19 | 14 | |
| 20 | 9 |
About Hirofumi Izaki
Hirofumi Izaki is a scholar working on Urology, Obstetrics and Gynecology and Pulmonary and Respiratory Medicine, having authored 55 papers that have together received 353 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (17 papers), Ureteral procedures and complications (11 papers) and Urological Disorders and Treatments (11 papers). The work is most often cited by research in Obstetrics and Gynecology (64 citations), Urology (40 citations) and Pulmonary and Respiratory Medicine (155 citations). Hirofumi Izaki has collaborated with scholars based in Japan and Egypt. Frequent co-authors include Hiro‐omi Kanayama, Tomoharu Fukumori, Masayuki Takahashi, Tomoteru Kishimoto, Natsuo Oka, Hiroyoshi Nakatsuji, Masaaki Nishitani, Kunihisa Yamaguchi, Takahiro Koizumi and Tomoya Fukawa. Their work appears in journals such as SHILAP Revista de lepidopterología, European Heart Journal and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.